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This new report (Fig. 1) makes the case for urgent action to 
halt and turn back the growing threat of chronic diseases. 
The full report and an overview pamphlet translated in 
several languages are available on the WHO website (http:
//www.who.int/chp/chronic_disease_report/contents/en/
index.html). This is a timely and very important document, 
nicely presented that describes risk factors and burden of 
chronic disease globally, reviews effective, feasible and 
evidence-based interventions for prevention and control of 
chronic diseases, provides practical suggestions for how 
countries can implement these interventions and outlines a 
public health approach to formulate and implement effective 
chronic disease policy and presents interventions. The pam-
phlet is very didactic, debunks wrong ideas about chronic 
diseases and describes poignant examples of the concrete 
implications of chronic diseases in developing countries.
The whole document is a great reading and should be known 
to everyone involved in public health. But there is a special 
domain in which the report is especially relevant to SPM: 
The emphasis on risk factor surveillance. The report refers 
to WHO STEPwise approach to Surveillance (STEPS) which 
has been described in a previous issue of SPM ([Strong and 
Bonita, 2004] and states that:
“Although some disease burden information may be avail-
able, the distribution of risk factors among the population is 
the key information required by countries in their planning 
of prevention and control programmes. This information 
predicts the future burden of disease; it must then be synthe-
sized and disseminated in a way that successfully argues the 
case for the adoption of relevant policies” (p. 126)
We would add that risk factors surveillance provides an early 
measurement of the impact of policies on population health: 
the incidence of coronary heart disease, of cancer or of diabe-
tes may still be on the rise long after their risk factors, such as 
obesity, hyperlipemia and sedentarity have started to regress.
One of the aims of 
SPM is to contrib-
ute to the process 
of synthesis and 
dissemination of 
risk factor surveil-
lance data. It is in 
this purpose that 
we have created the 
section on Interna-
tional Comparison 
of Health Determi-
nants, in which we 
invite the contribu-
tors to present their 
data in a standard-
ized format and 
compare them with previous reports. This section could 
be used more than it has been until now. We also view the 
SPM section Hints and Kinks as a place where people daily 
involved with risk factor surveillance can share their experi-
ence and disseminate their ways of improving the process. 
We would like to receive more papers for these two sections.
The need for surveillance data is enormous and the meth-
odological obstacles in collecting them, standardizing or 
homogenizing them on regional, national and global scales 
are Herculean. So what, Hercules did it after all.
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